A luminescent calcium biosensor enabling endpoint measurement of GPCR-mediated calcium signaling
G<sub>q/11</sub>-coupled GPCRs regulate critical physiological processes through calcium mobilization, making intracellular Ca<sup>2+</sup> dynamics a key readout for drug discovery and biomarker detection. However, the transient nature of calcium signals necessitates real-time monitoring with specialized equipment, creating barriers for high-throughput screening and limiting accessibility. Here we present CalLuc-2.1, a luminescent calcium biosensor that converts brief Ca<sup>2+</sup> spikes into persistent luminescence changes readable tens of minutes after stimulation. By eliminating the need for precisely-timed detection, CalLuc-2.1 enables endpoint measurement of GPCR activation using standard plate readers. We demonstrate robust performance (Z' > 0.88) across multiple G<sub>q/11</sub>-coupled GPCRs in both agonist and antagonist screening formats. Furthermore, CalLuc-2.1 successfully detects endogenous GPCR ligands directly in human serum, offering a simpler alternative to immunoassays and mass spectrometry for biomarker quantification. This approach makes calcium-based GPCR assays accessible to any laboratory with basic luminescence detection capabilities, potentially accelerating both drug discovery and clinical research applications.
Authors
- Ryoji Kise (ORCID: https://orcid.org/0009-0000-6583-1719)
- Masataka Yanagawa (ORCID: https://orcid.org/0000-0001-7832-0918)
- Kosuke Doi
- Kota Shimizume
- Asuka Inoue
Institutions
- Pioneer (United States) (US)
- Tohoku University (JP)
- Kyoto University (JP)
- Kyoto Pharmaceutical University (JP)
- Yamasa Corporation (Japan) (JP)
- Tohoku Medical and Pharmaceutical University (JP)
Publication Details
- Journal
- Communications Biology
- Published
- 2026-03-29
- DOI
- https://doi.org/10.1038/s42003-026-09920-4
- Primary Topic
- Receptor Mechanisms and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00